RB1 and metabolic disease: Interestingly, Rb1 treatment protected all these I/R-induced energy metabolism disorders in myocardium, as well as myocardium impairment, which pointed to the potential of Rb1 to relieve the disordered energy metabolism by regulation of ATP5D expression and ATP synthase activity.